Fundraising FoxBand of Angels — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
Combinati developed the QuantStudio Absolute Q Digital PCR System, which uses microfluidic array plate (MAP) technology for detection and quantification of nucleic acids, rare mutations, and genome editing events.
BiotechDeep TechHardwarePalo Alto, US
Michael Mokelke(Director)Ju-Sung (Paul) Hung(Executive Officer, Director)Charles Collins(Director)
Co-investorsBayMed Venture PartnersEndurance28IT-Farm Corporation
MuReva Phototherapy develops oral phototherapy devices intended to reduce dose-limiting side effects, such as oral mucositis, in cancer patients undergoing radiation and chemotherapy.
Advanced ManufacturingHardwareHealthtechMedical DevicesBrecksville, US
Vedang Kothari(President)Sam Shelnutt(Vice-President of Engineering)inMichael Marotta(Vice President of Clinical Affairs)inPeter Broer(Director)Creighton Murch(Director)Austin Ruhle(Chief Financial Officer)
Co-investorsAngel Physicians FundJumpstart Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.